1 / 9

Global Clinical Trial Imaging Market is Expected to Grow at a CAGR of 5.8 % by 2026

Clinical Trial Imaging Market Size, Share & Trends Analysis Report By End Use (CROs, Pharmaceutical Companies), By Service, By Modality (CT Scan, Ultrasound, MRI), And Segment Forecasts, 2018 - 2026

Marsh
Download Presentation

Global Clinical Trial Imaging Market is Expected to Grow at a CAGR of 5.8 % by 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Trial Imaging Market Analysis, Size, Growth, Share & Forecast to 2025 | Grand View Research Inc. “Clinical Trial Imaging Market Worth $1.31 Billion by 2026 | CAGR: 5.8%.” The global Clinical Trial Imaging Market size is expected to reach USD 1.31 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.8% during the forecast period. Increasing spending on research and development activities to develop new drugs and therapies to treat chronic diseases is boosting market growth. Clinical trials assist in the development, registration, and eventually access of new drugs to patients. Imaging helps in the process of drug development by offering non-invasive evaluation of drug action and response of tumor to treatment. Functional imaging techniques are progressively being used in early phases of clinical trials to study initial effects of drug action on parts of tumor biology including metabolism, cellularity, and vascularity. Contract Research Organizations (CROs) were the most prominent end-use segment in the market in 2017. Imaging modalities are used to determine indicators of pharmacological response to a therapy. Biomarkers and surrogate endpoints assist in obtaining quick results with good statistical power even in small sample sizes encouraging CROs to carryout multiple studies with reduced cost of operation. The market in Asia Pacific is projected to witness swift growth during the forecast period as the number of CROs and pharmaceutical organizations in the region are increasing in recent past due to low cost of labor and public and private funding offered in countries such as India and China. However, inaccessibility of trial protocols and poor quality of registered clinical trial data, results, and participant-level data undermined the potential benefits of clinical trial registration earlier. Nevertheless, emergence of national and regional registries and ICTRP have facilitated to overcome aforementioned barriers in APAC. Further key findings from the report suggest Follow Us:

  2. North America dominated the market in 2017. Attaining compliance with registration requires a combination of international and local measures and remains a key challenge in many countries. However, U.S. FDA and other regulatory organizations have played a leading role in attaining accomplishments of trial registration to date and is likely to be supported in tackling such challenges in the near future • Some of the players operating in this market are Parexel International Corporation; Intrinsic Imaging; Radiant Sage; Icon PLC; Worldcare Clinical; Bioclinica Inc.; Navitas Life Sciences; Resonance Health; Ixico PLC; and Medpace. • Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/clinical-trial- imaging-market Grand View Research has segmented the global clinical trial imaging market based on service, modalities, end-use, and region: Clinical Trial Imaging Service Outlook (Revenue, USD Million, 2014 - 2026) Clinical trial design and consultation services • Reading and analytical Services • Operational Imaging services • System and technology support services • Project and Data Management • Clinical Trial Imaging Modalities Outlook (Revenue, USD Million, 2014 - 2026) Computed Tomography (CT) Scan • MRI ( Magnetic Resonance Imaging) • X-Ray • Ultrasound • Optical Coherence Tomography (OCT) • Others (Positron Emission Tomography (PET), Single-Photon Emission Computerized Tomography (SPECT)Reading and analytical Services • Clinical Trial Imaging End-use Outlook (Revenue, USD Million, 2014 - 2026) Biotechnology and Pharmaceutical companies • Follow Us:

  3. Medical Devices Manufacturers • Academic and government research institutes • Contract Research Organization (CROs) • Others (Cosmetics and skin care industries) • Clinical Trial Imaging Regional Outlook (Revenue, USD Million, 2014 - 2026) North America • oU.S. oCanada Europe • oU.K. oGermany Asia Pacific • oIndia oChina Latin America • oBrazil oMexico Middle East & Africa • oSouth Africa oSaudi Arabia Table of Content Chapter 1 Report Scope 1.1 Segment Market Scope 1.2 Regional Scope 1.3 Estimates and Forecast Timeline Chapter 2 Methodology 2.1 Research Methodology Follow Us:

  4. 2.1.1 Information procurement 2.2 Information or Data Analysis 2.3 Market Formulation & Validation 2.4 Region Wise Market Calculation 2.4.1 Region Wise Market: Base Estimates 2.4.2 Global Market: CAGR Calculation 2.5 Region Based Segment Share Calculation 2.6 Model Details 2.6.1 Commodity flow analysis (Model 1) 2.6.2 Volume price analysis (model 2) 2.7 List of Secondary Sources 2.8 List of Primary Sources 2.9 List of Abbreviations Chapter 3 Objectives 3.1 Objective - 1: Understanding the market dynamics 3.2 Objective - 2: Understanding the market estimates and forecasts 3.3 Objective - 3: Understanding the attributes such as strategy framework, competitor categorization 3.4 Objective - 4: Understanding the key end-users, technological, application and product scopes Chapter 4 Executive Summary Chapter 5 Market Definition Chapter 6 Industry Outlook 6.1 Market Segmentation 6.2 Business Segment Trends 6.2.1 Product business analysis 6.2.2 Regional business analysis 6.3 Market Variable Analysis 6.3.1 Market driver analysis 6.3.1.1 Increasing demand for cosmetic dentistry 6.3.1.2 Growing prevalence of dental ailments 6.3.1.3 Increasing number of dental surgeries 6.3.2 Market restraint analysis 6.3.2.1 Stringent regulations on dental device sterilization 6.4 Business Environment Analysis tools Follow Us:

  5. 6.4.1 SWOT Analysis, by PEST 6.4.2 Porter’s five forces analysis 6.4.3 Industry Analysis - Ansoff Matrix Chapter 7 Competitive & Vendor Landscape 7.1 Participant Categorization 7.2 Strategy Mapping Chapter 8 Clinical Trial Imaging Market: Service Estimates & Trend Analysis 8.1 Clinical Trial Imaging Market: Service Movement Analysis 8.2 Clinical Trial Design and Consultation 8.2.1 Clinical trial design and consultation market estimates and forecasts, 2014 - 2026 (USD Million) 8.3 Reading and Analytical 8.3.1 Reading and analytical market estimates and forecasts, 2014 - 2026 (USD Million) 8.4 Operational Imaging 8.4.1 Operational imaging market estimates and forecasts, 2014 - 2026 (USD Million) 8.5 System and Technology Support 8.5.1 System and technology support market estimates and forecasts, 2014 - 2026 (USD Million) 8.6 Project and Data Management 8.6.1 Project and data management market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 9 Clinical Trial Imaging Market: Modalities Estimates & Trend Analysis 9.1 Clinical Trial Imaging Market: Service Movement Analysis 9.2 Computed Tomography (CT) Scan 9.2.1 Computed Tomography (CT) Scan market estimates and forecasts, 2014 - 2026 (USD Million) 9.3 Magnetic Resonance Imaging (MRI) 9.3.1 Magnetic Resonance Imaging (MRI) market estimates and forecasts, 2014 - 2026 (USD Million) 9.4 X-Ray 9.4.1 X-Ray market estimates and forecasts, 2014 - 2026 (USD Million) 9.5 Ultrasound 9.5.1 Ultrasound market estimates and forecasts, 2014 - 2026 (USD Million) 9.6 Optical Coherence Tomography (OCT) 9.6.1 Optical Coherence Tomography (OCT) market estimates and forecasts, 2014 - 2026 (USD Million) Follow Us:

  6. 9.7 Others 9.7.1 Others market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 10 Clinical Trial Imaging Market: End-use Estimates & Trend Analysis 10.1 Clinical Trial Imaging Market: End-use Movement Analysis 10.2 Biotechnology and Pharmaceutical Companies 10.2.1 Biotechnology and Pharmaceutical companies market estimates and forecasts, 2014 - 2026 (USD Million) 10.3 Medical Devices Manufacturers 10.3.1 Medical Devices Manufacturers market estimates and forecasts, 2014 - 2026 (USD Million) 10.4 Academic and government research institutes 10.4.1 Academic and government research institutes market estimates and forecasts, 2014 - 2026 (USD Million) 10.5 Contract Research Organization (CROs) 10.5.1 Contract Research Organization (CROs) market estimates and forecasts, 2014 - 2026 (USD Million) 10.6 Others 10.6.1 Others market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 11 Clinical Trial Imaging Market: Regional Estimates & Trend Analysis 11.1 Clinical Trial Imaging Market Share by Region, 2017 & 2026 11.2 North America 11.2.1 North America clinical trial imaging market, 2014 - 2026 (USD Million) 11.2.2 U.S. 11.2.2.1 U.S. clinical trial imaging market, 2014 - 2026 (USD Million) 11.2.3 Canada 11.2.3.1 Canada clinical trial imaging market, 2014 - 2026 (USD Million) 11.3 Europe 11.3.1 Europe clinical trial imaging market, 2014 - 2026 (USD Million) 11.3.2 U.K. 11.3.2.1 U.K. clinical trial imaging market, 2014 - 2026 (USD Million) 11.3.3 Germany 10.3.3.1 Germany clinical trial imaging market, 2014 - 2026 (USD Million) 11.4 Asia Pacific 11.4.1 Asia Pacific clinical trial imaging market, 2014 - 2026 (USD Million) 11.4.2 Japan Follow Us:

  7. 11.4.2.1 Japan clinical trial imaging market, 2014 - 2026 (USD Million) 11.4.3 China (Mainland) 11.4.3.1 China (Mainland) clinical trial imaging market, 2014 - 2026 (USD Million) 11.5 Latin America 11.5.1 Latin America clinical trial imaging market, 2014 - 2026 (USD Million) 11.5.2 Brazil 11.5.2.1 Brazil clinical trial imaging market, 2014 - 2026 (USD Million) 11.5.3 Mexico 11.5.3.1 Mexico clinical trial imaging market, 2014 - 2026 (USD Million) 11.6 MEA 11.6.1 MEA clinical trial imaging market, 2014 - 2026 (USD Million) 11.6.2 South Africa 11.6.2.1 South Africa clinical trial imaging market, 2014 - 2026 (USD Million) 11.6.3 Saudi Arabia 11.6.3.1 Saudi Arabia clinical trial imaging market, 2014 - 2026 (USD Million) Chapter 12 Company Profiles 12.1 Company Profiles 12.1.1 Bioclinica 12.1.1.1 Company overview 12.1.1.2 Financial performance 12.1.1.3 Product benchmarking 12.1.1.4 Strategic initiatives 12.1.2 ICON 12.1.2.1 Company overview 12.1.2.2 Financial performance 12.1.2.3 Product benchmarking 12.1.2.4 Strategic initiatives 12.1.3 IXICIO 12.1.3.1 Company overview 12.1.3.2 Financial performance 12.1.3.3 Product benchmarking 12.1.3.4 Strategic initiatives 12.1.4 Navitas life sciences 12.1.4.1 Company Overview Follow Us:

  8. 12.1.4.2 Financial performance 12.1.4.3 Product benchmarking 12.1.4.4 Strategic initiatives 12.1.5 Resonance Health 12.1.5.1 Company overview 12.1.5.2 Financial performance 12.1.5.3 Product benchmarking 12.1.5.4 Strategic initiatives 12.1.6 Worldcare Clinical 12.1.6.1 Company overview 12.1.6.2 Financial performance 12.1.6.3 Product benchmarking 12.1.6.4 Strategic initiatives 12.1.7 Intrinsic Imaging 12.1.7.1 Company overview 12.1.7.2 Financial performance 12.1.7.3 Product benchmarking 12.1.7.4 Strategic initiatives 12.1.8 Radiant Sage 12.1.8.1 Company overview 12.1.8.2 Financial performance 12.1.8.3 Product benchmarking 12.1.8.4 Strategic initiatives 12.1.9 Parexel International corporation 12.1.9.1 Company overview 12.1.9.2 Financial performance 12.1.9.3 Product benchmarking 12.1.9.4 Strategic initiatives 12.1.10 Medpace 12.1.10.1 Company overview 12.1.10.2 Financial performance 12.1.10.3 Product benchmarking 12.1.10.4 Strategic initiatives Follow Us:

  9. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us:

More Related